-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guide: Phlinmycin capsules are suitable for serious infections caused by sensitive anaerobic bacteria and severe infections caused by sensitive strains such as streptococcus, pneumococcal and staphylococcus. On August 6,
, a magenta pharmaceutical industry issued a notice, said that the company's subsidiary Guangzhou Magenta Pharmaceutical Co., Ltd. recently received the State Drug Administration approved the issuance of the "Drug Registration Certificate."
klinmycin capsules are suitable for serious infections caused by sensitive anaerobic bacteria and serious infections caused by sensitive strains such as streptococcus, pneumococcus and staphylococcus, but only in patients who are allergic to penicillin or who are judged by a doctor to use penicillin.
its applicable population includes adults and children (can swallow capsules).
Sales of clinmycin hydrochloride (oral products) in public hospitals in 2018 amounted to 880 million yuan, up 2.80 percent year-on-year, according to Miner.com.
hydrochloric acid klinmycin capsules in the domestic has entered the medical insurance Class A, base drug catalog, the company in accordance with the 2016 chemical drug registration classification reform program in the new registration classification declaration, as if through the consistency evaluation, wherein, the company's hydrochloric acid klinmycin capsule 300mg specifications for the exclusive through the drug registration products.
.